Preimplantation Genetic Diagnosis: Testing the Legal Boundaries

GENES, SOCIETY AND THE FUTURE: Vol. I, Part 2, Human Genome Research Project, Dunedin, NZ, 2007

120 Pages Posted: 2 May 2011

See all articles by Jeanne Snelling

Jeanne Snelling

University of Otago

Nicola Peart

Faculty of Law, University of Otago

Mark Henaghan

University of Otago; University of Otago

Date Written: May 1, 2011

Abstract

Preimplantation genetic diagnosis (PGD) constitutes one of the most significant medical innovations of the last two decades in the area of assisted reproductive technology. The information derived from the genetic analysis of cells aspirated from an embryo created by in vitro fertilisation (IVF) may be used for diverse purposes, all of which may influence the decision as to which embryos should be implanted, and which discarded. With the introduction of the Human Assisted Reproductive Technology (HART) Act 2004, the performance of PGD is now subject to legislative and regulatory restraint. The purpose of this report is to consider extensions to the current scope of permissible PGD in New Zealand, and to determine the effect of the HART Act 2004 provisions on decision-making in this area.

In view of developments in science and in other jurisdictions, it is likely that there will be a demand to extend the current ambit of the regulatory framework. Extending, or refusing to extend the current parameters for PGD will require a clear articulation of how the principles declared in the HART Act 2004 which govern decision-making in this area are to be applied.

This report examines the conducting of PGD in areas which would broaden the existing regulatory scheme. In the following section an analysis of the HART Act 2004, and in particular the purposes and principles of the Act, will be undertaken to provide a foundation for the substantive examination of expansions to PGD in the following sections. The expansions discussed in sections 3 and 4 involve human leukocyte antigen (HLA) tissue typing and negative selection of healthy carrier embryos, respectively. In a field of rapid scientific progress, the last section in this report provides an update regarding the most recent development in the field of PGD: preimplantation genetic haplotyping (PGH).

Keywords: Law, Genetics, Ethics, Human Genome, Genes

Suggested Citation

Snelling, Jeanne and Peart, Nicola and Henaghan, Mark, Preimplantation Genetic Diagnosis: Testing the Legal Boundaries (May 1, 2011). GENES, SOCIETY AND THE FUTURE: Vol. I, Part 2, Human Genome Research Project, Dunedin, NZ, 2007. Available at SSRN: https://ssrn.com/abstract=1828203

Jeanne Snelling

University of Otago ( email )

P.O. Box 56
Dunedin, Otago 9010
New Zealand
6434795093 (Phone)
6434798855 (Fax)

HOME PAGE: http://otago.ac.nz/law/genome

Nicola Peart

Faculty of Law, University of Otago ( email )

PO Box 56
Dunedin North
Dunedin, Otago 9016
New Zealand
6434798859 (Phone)
6434798855 (Fax)

HOME PAGE: http://www.otago.ac.nz/law/staff/nicola_peart.html

Mark Henaghan (Contact Author)

University of Otago ( email )

Faculty of Law
P.O. Box 56
Dunedin, 9054
New Zealand
64 3 479 5324 (Phone)
64 3 479 8855 (Fax)

HOME PAGE: http://otago.ac.nz/law/genome

University of Otago ( email )

PO Box 56
Dunedin North
Dunedin, 9016
New Zealand
6434798854 (Phone)
644798855 (Fax)

HOME PAGE: http://otago.ac.nz/law/genome

Register to save articles to
your library

Register

Paper statistics

Downloads
129
Abstract Views
1,130
rank
217,826
PlumX Metrics